Ligand | Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | |||||
Bictegravir | GP160_HIV1 | Envelope glycoprotein gp160 | -8.02 | -8.18 | -7.38 | N/A | N/A |
Paritaprevir | GP160_HIV1 | Envelope glycoprotein gp160 | -7.88 | -8.31 | -7.63 | N/A | N/A |
Glimepiride | GP160_HIV1 | Envelope glycoprotein gp160 | -8.99 | -8.92 | -9.47 | N/A | N/A |
Fedratinib | GP160_HIV1 | Envelope glycoprotein gp160 | -8.13 | -7.92 | -8.11 | N/A | N/A |
Oseltamivir | GP160_HIV1 | Envelope glycoprotein gp160 | -5.54 | -5.45 | -5.33 | N/A | N/A |
Bictegravir | GP160_HIV2 | Envelope glycoprotein gp160 | -8.60 | N/A | N/A | N/A | N/A |
Paritaprevir | GP160_HIV2 | Envelope glycoprotein gp160 | -8.83 | N/A | N/A | N/A | N/A |
Glimepiride | GP160_HIV2 | Envelope glycoprotein gp160 | -8.26 | N/A | N/A | N/A | N/A |
Fedratinib | GP160_HIV2 | Envelope glycoprotein gp160 | -6.88 | N/A | N/A | N/A | N/A |
Oseltamivir | GP160_HIV2 | Envelope glycoprotein gp160 | -5.15 | N/A | N/A | N/A | N/A |
Bictegravir | GP_EBOV | Envelope glycoprotein | -9.34 | -9.70 | -8.73 | 31.95% | CHEMBL3125895 |
Paritaprevir | GP_EBOV | Envelope glycoprotein | -9.87 | -9.28 | -9.51 | 39.82% | CHEMBL3125899 |
Glimepiride | GP_EBOV | Envelope glycoprotein | -8.85 | -8.74 | -7.96 | 23.78% | CHEMBL3125899 |
Fedratinib | GP_EBOV | Envelope glycoprotein | -8.22 | -8.69 | -7.68 | 24.66% | CHEMBL3125895 |
Oseltamivir | GP_EBOV | Envelope glycoprotein | -6.05 | -5.93 | -5.84 | 38.33% | CHEMBL3125897 |
Bictegravir | HA_A-H10N7 | Hemagglutinin | -8.76 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H10N7 | Hemagglutinin | -8.62 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H10N7 | Hemagglutinin | -7.60 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H10N7 | Hemagglutinin | -7.33 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H10N7 | Hemagglutinin | -5.51 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H10N8 | Hemagglutinin | -7.43 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H10N8 | Hemagglutinin | -8.14 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H10N8 | Hemagglutinin | -7.88 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H10N8 | Hemagglutinin | -6.49 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H10N8 | Hemagglutinin | -5.40 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H13N6 | Hemagglutinin | -8.31 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H13N6 | Hemagglutinin | -7.50 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H13N6 | Hemagglutinin | -7.85 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H13N6 | Hemagglutinin | -6.52 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H13N6 | Hemagglutinin | -5.46 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H14N6 | Hemagglutinin | -8.90 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H14N6 | Hemagglutinin | -8.72 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H14N6 | Hemagglutinin | -8.71 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H14N6 | Hemagglutinin | -7.31 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H14N6 | Hemagglutinin | -5.39 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H15N9 | Hemagglutinin | -8.31 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H15N9 | Hemagglutinin | -8.20 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H15N9 | Hemagglutinin | -8.20 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H15N9 | Hemagglutinin | -6.44 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H15N9 | Hemagglutinin | -5.33 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H17N10 | Hemagglutinin | -7.25 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H17N10 | Hemagglutinin | -8.20 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H17N10 | Hemagglutinin | -7.35 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H17N10 | Hemagglutinin | -6.67 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H17N10 | Hemagglutinin | -5.19 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H18N11 | Hemagglutinin | -6.53 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H18N11 | Hemagglutinin | -7.87 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H18N11 | Hemagglutinin | -6.38 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H18N11 | Hemagglutinin | -6.07 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H18N11 | Hemagglutinin | -4.99 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H1N1 | Hemagglutinin | -7.81 | -7.91 | N/A | N/A | N/A |
Paritaprevir | HA_A-H1N1 | Hemagglutinin | -8.75 | -8.69 | N/A | N/A | N/A |
Glimepiride | HA_A-H1N1 | Hemagglutinin | -7.70 | -8.52 | N/A | N/A | N/A |
Fedratinib | HA_A-H1N1 | Hemagglutinin | -6.67 | -6.74 | N/A | N/A | N/A |
Oseltamivir | HA_A-H1N1 | Hemagglutinin | -5.99 | -5.63 | N/A | N/A | N/A |
Bictegravir | HA_A-H2N2 | Hemagglutinin | -7.84 | -7.01 | N/A | N/A | N/A |
Paritaprevir | HA_A-H2N2 | Hemagglutinin | -8.04 | -8.05 | N/A | N/A | N/A |
Glimepiride | HA_A-H2N2 | Hemagglutinin | -7.40 | -7.37 | N/A | N/A | N/A |
Fedratinib | HA_A-H2N2 | Hemagglutinin | -7.11 | -6.23 | N/A | N/A | N/A |
Oseltamivir | HA_A-H2N2 | Hemagglutinin | -4.99 | -5.02 | N/A | N/A | N/A |
Bictegravir | HA_A-H3N2 | Hemagglutinin | -8.23 | -8.29 | -8.04 | N/A | N/A |
Paritaprevir | HA_A-H3N2 | Hemagglutinin | -8.90 | -8.56 | -9.26 | N/A | N/A |
Glimepiride | HA_A-H3N2 | Hemagglutinin | -7.72 | -7.86 | -7.72 | N/A | N/A |
Fedratinib | HA_A-H3N2 | Hemagglutinin | -7.02 | -6.63 | -6.34 | N/A | N/A |
Oseltamivir | HA_A-H3N2 | Hemagglutinin | -5.41 | -4.77 | -5.22 | N/A | N/A |
Bictegravir | HA_A-H3N8 | Hemagglutinin | -7.32 | -7.63 | -7.35 | N/A | N/A |
Paritaprevir | HA_A-H3N8 | Hemagglutinin | -7.58 | -7.70 | -8.26 | N/A | N/A |
Glimepiride | HA_A-H3N8 | Hemagglutinin | -6.54 | -6.95 | -7.24 | N/A | N/A |
Fedratinib | HA_A-H3N8 | Hemagglutinin | -7.10 | -6.29 | -7.14 | N/A | N/A |
Oseltamivir | HA_A-H3N8 | Hemagglutinin | -5.08 | -5.23 | -5.34 | N/A | N/A |
Bictegravir | HA_A-H5N1 | Hemagglutinin | -8.51 | -8.10 | -8.04 | N/A | N/A |
Paritaprevir | HA_A-H5N1 | Hemagglutinin | -7.82 | -7.45 | -8.11 | N/A | N/A |
Glimepiride | HA_A-H5N1 | Hemagglutinin | -8.42 | -8.22 | -7.73 | N/A | N/A |
Fedratinib | HA_A-H5N1 | Hemagglutinin | -6.50 | -7.36 | -6.95 | N/A | N/A |
Oseltamivir | HA_A-H5N1 | Hemagglutinin | -5.60 | -5.05 | -5.70 | N/A | N/A |
Bictegravir | HA_A-H5N3 | Hemagglutinin | -7.28 | -8.14 | N/A | N/A | N/A |
Paritaprevir | HA_A-H5N3 | Hemagglutinin | -7.86 | -7.40 | N/A | N/A | N/A |
Glimepiride | HA_A-H5N3 | Hemagglutinin | -6.84 | -7.82 | N/A | N/A | N/A |
Fedratinib | HA_A-H5N3 | Hemagglutinin | -6.72 | -6.28 | N/A | N/A | N/A |
Oseltamivir | HA_A-H5N3 | Hemagglutinin | -5.06 | -5.14 | N/A | N/A | N/A |
Bictegravir | HA_A-H6N1 | Hemagglutinin | -7.43 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H6N1 | Hemagglutinin | -8.14 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H6N1 | Hemagglutinin | -7.88 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H6N1 | Hemagglutinin | -6.49 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H6N1 | Hemagglutinin | -5.40 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H6N6 | Hemagglutinin | -7.89 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H6N6 | Hemagglutinin | -7.80 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H6N6 | Hemagglutinin | -7.28 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H6N6 | Hemagglutinin | -6.53 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H6N6 | Hemagglutinin | -5.63 | N/A | N/A | N/A | N/A |
Bictegravir | HA_A-H7N2 | Hemagglutinin | -7.41 | -7.32 | -7.32 | N/A | N/A |
Paritaprevir | HA_A-H7N2 | Hemagglutinin | -8.64 | -7.63 | -8.01 | N/A | N/A |
Glimepiride | HA_A-H7N2 | Hemagglutinin | -7.30 | -7.23 | -7.47 | N/A | N/A |
Fedratinib | HA_A-H7N2 | Hemagglutinin | -5.94 | -6.34 | -5.87 | N/A | N/A |
Oseltamivir | HA_A-H7N2 | Hemagglutinin | -5.36 | -4.98 | -5.20 | N/A | N/A |
Bictegravir | HA_A-H7N7 | Hemagglutinin | -7.31 | -8.91 | N/A | N/A | N/A |
Paritaprevir | HA_A-H7N7 | Hemagglutinin | -7.90 | -8.18 | N/A | N/A | N/A |
Glimepiride | HA_A-H7N7 | Hemagglutinin | -6.91 | -7.22 | N/A | N/A | N/A |
Fedratinib | HA_A-H7N7 | Hemagglutinin | -5.48 | -7.52 | N/A | N/A | N/A |
Oseltamivir | HA_A-H7N7 | Hemagglutinin | -5.29 | -5.09 | N/A | N/A | N/A |
Bictegravir | HA_A-H7N9 | Hemagglutinin | -7.74 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_A-H7N9 | Hemagglutinin | -8.27 | N/A | N/A | N/A | N/A |
Glimepiride | HA_A-H7N9 | Hemagglutinin | -7.61 | N/A | N/A | N/A | N/A |
Fedratinib | HA_A-H7N9 | Hemagglutinin | -6.95 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_A-H7N9 | Hemagglutinin | -5.85 | N/A | N/A | N/A | N/A |
Bictegravir | HA_INFB | Hemagglutinin | -7.97 | -8.24 | N/A | N/A | N/A |
Paritaprevir | HA_INFB | Hemagglutinin | -8.70 | -7.79 | N/A | N/A | N/A |
Glimepiride | HA_INFB | Hemagglutinin | -7.33 | -7.34 | N/A | N/A | N/A |
Fedratinib | HA_INFB | Hemagglutinin | -7.29 | -6.71 | N/A | N/A | N/A |
Oseltamivir | HA_INFB | Hemagglutinin | -5.41 | -5.05 | N/A | N/A | N/A |
Bictegravir | HA_INFD | Hemagglutinin-esterase-fusion glycoprotein | -6.75 | N/A | N/A | N/A | N/A |
Paritaprevir | HA_INFD | Hemagglutinin-esterase-fusion glycoprotein | -7.67 | N/A | N/A | N/A | N/A |
Glimepiride | HA_INFD | Hemagglutinin-esterase-fusion glycoprotein | -7.36 | N/A | N/A | N/A | N/A |
Fedratinib | HA_INFD | Hemagglutinin-esterase-fusion glycoprotein | -6.07 | N/A | N/A | N/A | N/A |
Oseltamivir | HA_INFD | Hemagglutinin-esterase-fusion glycoprotein | -5.22 | N/A | N/A | N/A | N/A |
Bictegravir | HE_BCV | Hemagglutinin-esterase | -8.44 | -7.89 | N/A | N/A | N/A |
Paritaprevir | HE_BCV | Hemagglutinin-esterase | -9.07 | -7.98 | N/A | N/A | N/A |
Glimepiride | HE_BCV | Hemagglutinin-esterase | -8.16 | -6.69 | N/A | N/A | N/A |
Fedratinib | HE_BCV | Hemagglutinin-esterase | -6.68 | -6.97 | N/A | N/A | N/A |
Oseltamivir | HE_BCV | Hemagglutinin-esterase | -6.35 | -5.36 | N/A | N/A | N/A |
Bictegravir | HE_HCoV-OC43 | Hemagglutinin-esterase | -7.02 | N/A | N/A | N/A | N/A |
Paritaprevir | HE_HCoV-OC43 | Hemagglutinin-esterase | -7.87 | N/A | N/A | N/A | N/A |
Glimepiride | HE_HCoV-OC43 | Hemagglutinin-esterase | -7.42 | N/A | N/A | N/A | N/A |
Fedratinib | HE_HCoV-OC43 | Hemagglutinin-esterase | -6.45 | N/A | N/A | N/A | N/A |
Oseltamivir | HE_HCoV-OC43 | Hemagglutinin-esterase | -4.83 | N/A | N/A | N/A | N/A |
Bictegravir | HE_MHV | Hemagglutinin-esterase | -7.29 | N/A | N/A | N/A | N/A |
Paritaprevir | HE_MHV | Hemagglutinin-esterase | -9.00 | N/A | N/A | N/A | N/A |
Glimepiride | HE_MHV | Hemagglutinin-esterase | -7.23 | N/A | N/A | N/A | N/A |
Fedratinib | HE_MHV | Hemagglutinin-esterase | -6.98 | N/A | N/A | N/A | N/A |
Oseltamivir | HE_MHV | Hemagglutinin-esterase | -5.41 | N/A | N/A | N/A | N/A |
Bictegravir | IN_HIV1 | Gag-Pol polyprotein | -6.27 | -7.20 | N/A | N/A | N/A |
Paritaprevir | IN_HIV1 | Gag-Pol polyprotein | -7.07 | -8.25 | N/A | N/A | N/A |
Glimepiride | IN_HIV1 | Gag-Pol polyprotein | -6.09 | -7.16 | N/A | N/A | N/A |
Fedratinib | IN_HIV1 | Gag-Pol polyprotein | -6.46 | -6.75 | N/A | N/A | N/A |
Oseltamivir | IN_HIV1 | Gag-Pol polyprotein | -4.49 | -4.38 | N/A | N/A | N/A |
Bictegravir | MD_HKU4 | Replicase polyprotein 1ab | -10.19 | -10.05 | -10.16 | N/A | N/A |
Paritaprevir | MD_HKU4 | Replicase polyprotein 1ab | -8.00 | -8.20 | -8.25 | N/A | N/A |
Glimepiride | MD_HKU4 | Replicase polyprotein 1ab | -10.07 | -10.36 | -10.06 | N/A | N/A |
Fedratinib | MD_HKU4 | Replicase polyprotein 1ab | -9.97 | -9.03 | -9.24 | N/A | N/A |
Oseltamivir | MD_HKU4 | Replicase polyprotein 1ab | -6.65 | -6.43 | -6.31 | N/A | N/A |
Bictegravir | MD_MERs | Replicase polyprotein 1a | -10.38 | -10.08 | N/A | N/A | N/A |
Paritaprevir | MD_MERs | Replicase polyprotein 1a | -9.12 | -9.72 | N/A | N/A | N/A |
Glimepiride | MD_MERs | Replicase polyprotein 1a | -10.10 | -9.94 | N/A | N/A | N/A |
Fedratinib | MD_MERs | Replicase polyprotein 1a | -9.21 | -8.72 | N/A | N/A | N/A |
Oseltamivir | MD_MERs | Replicase polyprotein 1a | -6.74 | -6.32 | N/A | N/A | N/A |
Bictegravir | MX2_A-H5N1 | Matrix protein 2 | -10.01 | N/A | N/A | N/A | N/A |
Paritaprevir | MX2_A-H5N1 | Matrix protein 2 | 51.43 | N/A | N/A | N/A | N/A |
Glimepiride | MX2_A-H5N1 | Matrix protein 2 | -3.87 | N/A | N/A | N/A | N/A |
Fedratinib | MX2_A-H5N1 | Matrix protein 2 | -1.61 | N/A | N/A | N/A | N/A |
Oseltamivir | MX2_A-H5N1 | Matrix protein 2 | -7.61 | N/A | N/A | N/A | N/A |
Bictegravir | NA_A-H11N6 | Neuraminidase | -9.92 | -9.55 | -9.60 | N/A | N/A |
Paritaprevir | NA_A-H11N6 | Neuraminidase | -8.91 | -9.11 | -9.43 | N/A | N/A |
Glimepiride | NA_A-H11N6 | Neuraminidase | -8.57 | -8.32 | -8.70 | N/A | N/A |
Fedratinib | NA_A-H11N6 | Neuraminidase | -8.32 | -8.68 | -8.42 | N/A | N/A |
Oseltamivir | NA_A-H11N6 | Neuraminidase | -6.72 | -6.44 | -6.47 | N/A | N/A |
Bictegravir | NA_A-H11N9 | Neuraminidase | -8.21 | -9.74 | -9.42 | N/A | N/A |
Paritaprevir | NA_A-H11N9 | Neuraminidase | -9.03 | -10.42 | -10.57 | N/A | N/A |
Glimepiride | NA_A-H11N9 | Neuraminidase | -8.25 | -8.72 | -8.81 | N/A | N/A |
Fedratinib | NA_A-H11N9 | Neuraminidase | -7.01 | -8.56 | -8.05 | N/A | N/A |
Oseltamivir | NA_A-H11N9 | Neuraminidase | -5.92 | -6.51 | -6.50 | N/A | N/A |
Bictegravir | NA_A-H12N5 | Neuraminidase | -9.74 | -9.61 | -9.66 | N/A | N/A |
Paritaprevir | NA_A-H12N5 | Neuraminidase | -9.25 | -9.25 | -10.01 | N/A | N/A |
Glimepiride | NA_A-H12N5 | Neuraminidase | -8.40 | -8.17 | -8.36 | N/A | N/A |
Fedratinib | NA_A-H12N5 | Neuraminidase | -7.77 | -8.44 | -7.93 | N/A | N/A |
Oseltamivir | NA_A-H12N5 | Neuraminidase | -6.18 | -6.78 | -6.73 | N/A | N/A |
Bictegravir | NA_A-H13N9 | Neuraminidase | -8.35 | N/A | N/A | N/A | N/A |
Paritaprevir | NA_A-H13N9 | Neuraminidase | -8.26 | N/A | N/A | N/A | N/A |
Glimepiride | NA_A-H13N9 | Neuraminidase | -6.73 | N/A | N/A | N/A | N/A |
Fedratinib | NA_A-H13N9 | Neuraminidase | -6.74 | N/A | N/A | N/A | N/A |
Oseltamivir | NA_A-H13N9 | Neuraminidase | -5.29 | N/A | N/A | N/A | N/A |
Bictegravir | NA_A-H17N10 | Neuraminidase | -9.07 | N/A | N/A | N/A | N/A |
Paritaprevir | NA_A-H17N10 | Neuraminidase | -9.59 | N/A | N/A | N/A | N/A |
Glimepiride | NA_A-H17N10 | Neuraminidase | -8.15 | N/A | N/A | N/A | N/A |
Fedratinib | NA_A-H17N10 | Neuraminidase | -7.44 | N/A | N/A | N/A | N/A |
Oseltamivir | NA_A-H17N10 | Neuraminidase | -5.45 | N/A | N/A | N/A | N/A |
Bictegravir | NA_A-H18N11 | Neuraminidase | -8.37 | N/A | N/A | N/A | N/A |
Paritaprevir | NA_A-H18N11 | Neuraminidase | -9.36 | N/A | N/A | N/A | N/A |
Glimepiride | NA_A-H18N11 | Neuraminidase | -7.36 | N/A | N/A | N/A | N/A |
Fedratinib | NA_A-H18N11 | Neuraminidase | -7.19 | N/A | N/A | N/A | N/A |
Oseltamivir | NA_A-H18N11 | Neuraminidase | -5.23 | N/A | N/A | N/A | N/A |
Bictegravir | NA_A-H1N1 | Neuraminidase | -9.58 | N/A | N/A | N/A | N/A |
Paritaprevir | NA_A-H1N1 | Neuraminidase | -10.13 | N/A | N/A | N/A | N/A |
Glimepiride | NA_A-H1N1 | Neuraminidase | -8.84 | N/A | N/A | N/A | N/A |
Fedratinib | NA_A-H1N1 | Neuraminidase | -8.08 | N/A | N/A | N/A | N/A |
Oseltamivir | NA_A-H1N1 | Neuraminidase | -6.22 | N/A | N/A | N/A | N/A |
Bictegravir | NA_A-H2N2 | Neuraminidase | -8.68 | -10.03 | -9.34 | N/A | N/A |
Paritaprevir | NA_A-H2N2 | Neuraminidase | -9.74 | -10.52 | -10.64 | N/A | N/A |
Glimepiride | NA_A-H2N2 | Neuraminidase | -8.09 | -9.35 | -8.91 | N/A | N/A |
Fedratinib | NA_A-H2N2 | Neuraminidase | -7.32 | -8.41 | -8.46 | N/A | N/A |
Oseltamivir | NA_A-H2N2 | Neuraminidase | -6.42 | -5.84 | -6.09 | N/A | N/A |
Bictegravir | NA_A-H3N2 | Ig heavy chain Mem5 | -9.29 | -9.28 | N/A | N/A | N/A |
Paritaprevir | NA_A-H3N2 | Ig heavy chain Mem5 | -9.33 | -8.41 | N/A | N/A | N/A |
Glimepiride | NA_A-H3N2 | Ig heavy chain Mem5 | -7.95 | -7.39 | N/A | N/A | N/A |
Fedratinib | NA_A-H3N2 | Ig heavy chain Mem5 | -7.99 | -7.02 | N/A | N/A | N/A |
Oseltamivir | NA_A-H3N2 | Ig heavy chain Mem5 | -5.78 | -5.80 | N/A | N/A | N/A |
Bictegravir | NA_A-H3N8 | Neuraminidase | -9.62 | -9.33 | -10.04 | N/A | N/A |
Paritaprevir | NA_A-H3N8 | Neuraminidase | -9.92 | -10.94 | -10.11 | N/A | N/A |
Glimepiride | NA_A-H3N8 | Neuraminidase | -8.08 | -10.00 | -8.08 | N/A | N/A |
Fedratinib | NA_A-H3N8 | Neuraminidase | -8.10 | -8.90 | -7.86 | N/A | N/A |
Oseltamivir | NA_A-H3N8 | Neuraminidase | -6.18 | -6.26 | -6.33 | N/A | N/A |
Bictegravir | NA_A-H5N1 | Neuraminidase | -9.17 | N/A | N/A | N/A | N/A |
Paritaprevir | NA_A-H5N1 | Neuraminidase | -9.68 | N/A | N/A | N/A | N/A |
Glimepiride | NA_A-H5N1 | Neuraminidase | -9.96 | N/A | N/A | N/A | N/A |
Fedratinib | NA_A-H5N1 | Neuraminidase | -8.66 | N/A | N/A | N/A | N/A |
Oseltamivir | NA_A-H5N1 | Neuraminidase | -6.17 | N/A | N/A | N/A | N/A |
Bictegravir | NA_A-H7N9 | Neuraminidase | -9.64 | -9.85 | -9.61 | N/A | N/A |
Paritaprevir | NA_A-H7N9 | Neuraminidase | -10.54 | -9.96 | -10.23 | N/A | N/A |
Glimepiride | NA_A-H7N9 | Neuraminidase | -8.60 | -9.23 | -8.94 | N/A | N/A |
Fedratinib | NA_A-H7N9 | Neuraminidase | -8.43 | -8.17 | -8.44 | N/A | N/A |
Oseltamivir | NA_A-H7N9 | Neuraminidase | -6.29 | -6.60 | -6.48 | N/A | N/A |
Bictegravir | NA_INFB | Neuraminidase | -8.98 | -8.55 | N/A | 31.12% | CHEMBL4175983 |
Paritaprevir | NA_INFB | Neuraminidase | -7.58 | -7.37 | N/A | 39.83% | CHEMBL254679 |
Glimepiride | NA_INFB | Neuraminidase | -7.96 | -8.33 | N/A | 37.57% | CHEMBL113191 |
Fedratinib | NA_INFB | Neuraminidase | -7.40 | -7.90 | N/A | 22.56% | CHEMBL195288 |
Oseltamivir | NA_INFB | Neuraminidase | -6.57 | -5.88 | N/A | 100.00% | CHEMBL1229 |
Bictegravir | NP_A-H1N1 | Nucleoprotein | -7.85 | -8.37 | -8.73 | N/A | N/A |
Paritaprevir | NP_A-H1N1 | Nucleoprotein | -8.21 | -7.94 | -7.84 | N/A | N/A |
Glimepiride | NP_A-H1N1 | Nucleoprotein | -7.41 | -7.06 | -8.15 | N/A | N/A |
Fedratinib | NP_A-H1N1 | Nucleoprotein | -5.56 | -7.67 | -7.35 | N/A | N/A |
Oseltamivir | NP_A-H1N1 | Nucleoprotein | -5.23 | -6.32 | -5.23 | N/A | N/A |
Bictegravir | NP_A-H5N1 | Nucleoprotein | -8.04 | N/A | N/A | N/A | N/A |
Paritaprevir | NP_A-H5N1 | Nucleoprotein | -7.92 | N/A | N/A | N/A | N/A |
Glimepiride | NP_A-H5N1 | Nucleoprotein | -7.67 | N/A | N/A | N/A | N/A |
Fedratinib | NP_A-H5N1 | Nucleoprotein | -7.47 | N/A | N/A | N/A | N/A |
Oseltamivir | NP_A-H5N1 | Nucleoprotein | -5.80 | N/A | N/A | N/A | N/A |
Bictegravir | NP_HCoV-NL63 | Nucleoprotein | -9.22 | N/A | N/A | N/A | N/A |
Paritaprevir | NP_HCoV-NL63 | Nucleoprotein | -8.83 | N/A | N/A | N/A | N/A |
Glimepiride | NP_HCoV-NL63 | Nucleoprotein | -7.96 | N/A | N/A | N/A | N/A |
Fedratinib | NP_HCoV-NL63 | Nucleoprotein | -7.71 | N/A | N/A | N/A | N/A |
Oseltamivir | NP_HCoV-NL63 | Nucleoprotein | -5.43 | N/A | N/A | N/A | N/A |
Bictegravir | NP_HCoV-OC43 | Nucleoprotein | -11.95 | -8.99 | -8.08 | 15.54% | CHEMBL3233481 |
Paritaprevir | NP_HCoV-OC43 | Nucleoprotein | -10.45 | -9.35 | -8.84 | 16.54% | CHEMBL3233481 |
Glimepiride | NP_HCoV-OC43 | Nucleoprotein | -9.87 | -9.36 | -7.64 | 10.91% | CHEMBL3233481 |
Fedratinib | NP_HCoV-OC43 | Nucleoprotein | -9.38 | -7.15 | -6.68 | 13.04% | CHEMBL3233481 |
Oseltamivir | NP_HCoV-OC43 | Nucleoprotein | -6.37 | -6.17 | -6.04 | 8.75% | CHEMBL3233481 |
Bictegravir | NP_INFB | Nucleoprotein | -6.17 | N/A | N/A | N/A | N/A |
Paritaprevir | NP_INFB | Nucleoprotein | -6.95 | N/A | N/A | N/A | N/A |
Glimepiride | NP_INFB | Nucleoprotein | -6.12 | N/A | N/A | N/A | N/A |
Fedratinib | NP_INFB | Nucleoprotein | -5.89 | N/A | N/A | N/A | N/A |
Oseltamivir | NP_INFB | Nucleoprotein | -4.15 | N/A | N/A | N/A | N/A |
Bictegravir | NP_INFD | NP | -6.72 | N/A | N/A | N/A | N/A |
Paritaprevir | NP_INFD | NP | -6.71 | N/A | N/A | N/A | N/A |
Glimepiride | NP_INFD | NP | -6.46 | N/A | N/A | N/A | N/A |
Fedratinib | NP_INFD | NP | -5.56 | N/A | N/A | N/A | N/A |
Oseltamivir | NP_INFD | NP | -4.24 | N/A | N/A | N/A | N/A |
Bictegravir | NP_SARS | Nucleoprotein | -9.04 | N/A | N/A | N/A | N/A |
Paritaprevir | NP_SARS | Nucleoprotein | -8.23 | N/A | N/A | N/A | N/A |
Glimepiride | NP_SARS | Nucleoprotein | -8.47 | N/A | N/A | N/A | N/A |
Fedratinib | NP_SARS | Nucleoprotein | -7.44 | N/A | N/A | N/A | N/A |
Oseltamivir | NP_SARS | Nucleoprotein | -6.49 | N/A | N/A | N/A | N/A |
Bictegravir | NS3_HCV1A | Genome polyprotein | -7.77 | -7.76 | -9.84 | 37.41% | CHEMBL3645743 |
Paritaprevir | NS3_HCV1A | Genome polyprotein | -8.85 | -8.17 | -8.56 | 54.15% | CHEMBL3645617 |
Glimepiride | NS3_HCV1A | Genome polyprotein | -10.06 | -6.81 | -9.25 | 34.97% | CHEMBL3645675 |
Fedratinib | NS3_HCV1A | Genome polyprotein | -7.54 | -6.30 | -7.12 | 35.36% | CHEMBL3913754 |
Oseltamivir | NS3_HCV1A | Genome polyprotein | -5.17 | -5.10 | -5.16 | 39.16% | CHEMBL3645746 |
Bictegravir | NS3_HCV1B | Genome polyprotein | -10.06 | -10.79 | -7.31 | 35.82% | CHEMBL3954962 |
Paritaprevir | NS3_HCV1B | Genome polyprotein | -9.04 | -8.71 | -8.55 | 49.70% | CHEMBL297884 |
Glimepiride | NS3_HCV1B | Genome polyprotein | -9.53 | -10.35 | -6.24 | 30.50% | CHEMBL1170417 |
Fedratinib | NS3_HCV1B | Genome polyprotein | -10.49 | -8.27 | -6.53 | 27.82% | CHEMBL1170417 |
Oseltamivir | NS3_HCV1B | Genome polyprotein | -5.44 | -5.43 | -5.05 | 38.00% | CHEMBL3927196 |
Bictegravir | NS3_HCV3A | Genome polyprotein | -9.34 | -9.04 | -7.87 | N/A | N/A |
Paritaprevir | NS3_HCV3A | Genome polyprotein | -8.78 | -8.83 | -9.12 | N/A | N/A |
Glimepiride | NS3_HCV3A | Genome polyprotein | -7.61 | -6.94 | -7.67 | N/A | N/A |
Fedratinib | NS3_HCV3A | Genome polyprotein | -7.42 | -7.26 | -7.17 | N/A | N/A |
Oseltamivir | NS3_HCV3A | Genome polyprotein | -5.63 | -5.35 | -5.70 | N/A | N/A |
Bictegravir | NS5B_HCV1A | Genome polyprotein | -10.61 | -9.96 | -10.18 | 36.11% | CHEMBL3644880 |
Paritaprevir | NS5B_HCV1A | Genome polyprotein | -11.22 | -11.31 | -10.32 | 48.76% | CHEMBL3644934 |
Glimepiride | NS5B_HCV1A | Genome polyprotein | -9.38 | -10.33 | -10.10 | 41.28% | CHEMBL3644895 |
Fedratinib | NS5B_HCV1A | Genome polyprotein | -8.30 | -9.47 | -9.02 | 27.93% | CHEMBL3644940 |
Oseltamivir | NS5B_HCV1A | Genome polyprotein | -5.86 | -6.56 | -6.78 | 32.87% | CHEMBL13443 |
Bictegravir | NS5B_HCV1B | Genome polyprotein | -9.58 | -9.62 | -8.92 | 36.31% | CHEMBL3645214 |
Paritaprevir | NS5B_HCV1B | Genome polyprotein | -10.71 | -9.09 | -8.62 | 39.44% | CHEMBL3645199 |
Glimepiride | NS5B_HCV1B | Genome polyprotein | -9.11 | -8.99 | -8.90 | 26.69% | CHEMBL3645210 |
Fedratinib | NS5B_HCV1B | Genome polyprotein | -7.80 | -8.28 | -8.18 | 32.39% | CHEMBL3645179 |
Oseltamivir | NS5B_HCV1B | Genome polyprotein | -6.32 | -6.66 | -6.64 | 22.18% | CHEMBL3645202 |
Bictegravir | NS5B_HCV2A | Genome polyprotein | -11.00 | -10.69 | N/A | N/A | N/A |
Paritaprevir | NS5B_HCV2A | Genome polyprotein | -9.32 | -5.12 | N/A | N/A | N/A |
Glimepiride | NS5B_HCV2A | Genome polyprotein | -10.11 | -11.66 | N/A | N/A | N/A |
Fedratinib | NS5B_HCV2A | Genome polyprotein | -10.48 | -6.70 | N/A | N/A | N/A |
Oseltamivir | NS5B_HCV2A | Genome polyprotein | -7.46 | -7.49 | N/A | N/A | N/A |
Bictegravir | NSP15_SARS | Replicase polyprotein 1ab | -7.79 | N/A | N/A | 24.29% | CHEMBL2441745 |
Paritaprevir | NSP15_SARS | Replicase polyprotein 1ab | -7.86 | N/A | N/A | 26.37% | CHEMBL2441741 |
Glimepiride | NSP15_SARS | Replicase polyprotein 1ab | -7.83 | N/A | N/A | 31.07% | CHEMBL2441741 |
Fedratinib | NSP15_SARS | Replicase polyprotein 1ab | -7.00 | N/A | N/A | 17.89% | CHEMBL2441741 |
Oseltamivir | NSP15_SARS | Replicase polyprotein 1ab | -4.93 | N/A | N/A | 25.41% | CHEMBL2441745 |
Bictegravir | NSP1_INFB | Non-structural protein 1 | -7.15 | -7.45 | N/A | N/A | N/A |
Paritaprevir | NSP1_INFB | Non-structural protein 1 | -8.23 | -8.87 | N/A | N/A | N/A |
Glimepiride | NSP1_INFB | Non-structural protein 1 | -5.95 | -6.93 | N/A | N/A | N/A |
Fedratinib | NSP1_INFB | Non-structural protein 1 | -6.90 | -6.91 | N/A | N/A | N/A |
Oseltamivir | NSP1_INFB | Non-structural protein 1 | -4.58 | -4.65 | N/A | N/A | N/A |
Bictegravir | NSP1_SARS | Replicase polyprotein 1ab | -8.13 | N/A | N/A | 24.29% | CHEMBL2441745 |
Paritaprevir | NSP1_SARS | Replicase polyprotein 1ab | -6.49 | N/A | N/A | 26.37% | CHEMBL2441741 |
Glimepiride | NSP1_SARS | Replicase polyprotein 1ab | -7.18 | N/A | N/A | 31.07% | CHEMBL2441741 |
Fedratinib | NSP1_SARS | Replicase polyprotein 1ab | -7.25 | N/A | N/A | 17.89% | CHEMBL2441741 |
Oseltamivir | NSP1_SARS | Replicase polyprotein 1ab | -5.40 | N/A | N/A | 25.41% | CHEMBL2441745 |
Bictegravir | NSP3_HCoV-229E | Replicase polyprotein 1a | -11.83 | N/A | N/A | N/A | N/A |
Paritaprevir | NSP3_HCoV-229E | Replicase polyprotein 1a | -10.48 | N/A | N/A | N/A | N/A |
Glimepiride | NSP3_HCoV-229E | Replicase polyprotein 1a | -11.31 | N/A | N/A | N/A | N/A |
Fedratinib | NSP3_HCoV-229E | Replicase polyprotein 1a | -9.61 | N/A | N/A | N/A | N/A |
Oseltamivir | NSP3_HCoV-229E | Replicase polyprotein 1a | -7.36 | N/A | N/A | N/A | N/A |
Bictegravir | NSP3_IBV | Replicase polyprotein 1a | -10.98 | N/A | N/A | N/A | N/A |
Paritaprevir | NSP3_IBV | Replicase polyprotein 1a | -8.35 | N/A | N/A | N/A | N/A |
Glimepiride | NSP3_IBV | Replicase polyprotein 1a | -11.16 | N/A | N/A | N/A | N/A |
Fedratinib | NSP3_IBV | Replicase polyprotein 1a | -8.78 | N/A | N/A | N/A | N/A |
Oseltamivir | NSP3_IBV | Replicase polyprotein 1a | -6.65 | N/A | N/A | N/A | N/A |
Bictegravir | NSP3_MHV | Replicase polyprotein 1ab | -7.29 | N/A | N/A | N/A | N/A |
Paritaprevir | NSP3_MHV | Replicase polyprotein 1ab | -6.98 | N/A | N/A | N/A | N/A |
Glimepiride | NSP3_MHV | Replicase polyprotein 1ab | -7.74 | N/A | N/A | N/A | N/A |
Fedratinib | NSP3_MHV | Replicase polyprotein 1ab | -6.81 | N/A | N/A | N/A | N/A |
Oseltamivir | NSP3_MHV | Replicase polyprotein 1ab | -5.11 | N/A | N/A | N/A | N/A |
Bictegravir | NSP9_HCoV-229E | Replicase polyprotein 1ab | -8.08 | -8.22 | N/A | N/A | N/A |
Paritaprevir | NSP9_HCoV-229E | Replicase polyprotein 1ab | -7.93 | -8.08 | N/A | N/A | N/A |
Glimepiride | NSP9_HCoV-229E | Replicase polyprotein 1ab | -6.91 | -7.54 | N/A | N/A | N/A |
Fedratinib | NSP9_HCoV-229E | Replicase polyprotein 1ab | -7.12 | -6.77 | N/A | N/A | N/A |
Oseltamivir | NSP9_HCoV-229E | Replicase polyprotein 1ab | -5.47 | -5.31 | N/A | N/A | N/A |
Bictegravir | PA_A-H17N10 | Polymerase acidic protein | -9.52 | N/A | N/A | N/A | N/A |
Paritaprevir | PA_A-H17N10 | Polymerase acidic protein | -10.35 | N/A | N/A | N/A | N/A |
Glimepiride | PA_A-H17N10 | Polymerase acidic protein | -9.04 | N/A | N/A | N/A | N/A |
Fedratinib | PA_A-H17N10 | Polymerase acidic protein | -8.10 | N/A | N/A | N/A | N/A |
Oseltamivir | PA_A-H17N10 | Polymerase acidic protein | -5.93 | N/A | N/A | N/A | N/A |
Bictegravir | PA_A-H1N1 | Polymerase acidic protein | -10.75 | -9.31 | -10.06 | N/A | N/A |
Paritaprevir | PA_A-H1N1 | Polymerase acidic protein | -9.89 | -10.98 | -10.54 | N/A | N/A |
Glimepiride | PA_A-H1N1 | Polymerase acidic protein | -8.00 | -9.55 | -9.55 | N/A | N/A |
Fedratinib | PA_A-H1N1 | Polymerase acidic protein | -8.86 | -8.53 | -8.96 | N/A | N/A |
Oseltamivir | PA_A-H1N1 | Polymerase acidic protein | -5.87 | -6.03 | -5.93 | N/A | N/A |
Bictegravir | PA_A-H5N1 | Polymerase acidic protein | -10.31 | -10.27 | -10.01 | N/A | N/A |
Paritaprevir | PA_A-H5N1 | Polymerase acidic protein | -11.43 | -9.82 | -10.72 | N/A | N/A |
Glimepiride | PA_A-H5N1 | Polymerase acidic protein | -9.75 | -8.26 | -9.54 | N/A | N/A |
Fedratinib | PA_A-H5N1 | Polymerase acidic protein | -8.64 | -8.44 | -8.24 | N/A | N/A |
Oseltamivir | PA_A-H5N1 | Polymerase acidic protein | -6.21 | -6.14 | -6.44 | N/A | N/A |
Bictegravir | PA_INFA | Polymerase acidic protein | -11.04 | -9.45 | -9.72 | 30.00% | CHEMBL2040578 |
Paritaprevir | PA_INFA | Polymerase acidic protein | -9.10 | -10.13 | -10.77 | 28.62% | CHEMBL2040640 |
Glimepiride | PA_INFA | Polymerase acidic protein | -8.54 | -8.41 | -9.07 | 34.95% | CHEMBL2040640 |
Fedratinib | PA_INFA | Polymerase acidic protein | -8.37 | -7.91 | -8.35 | 20.83% | CHEMBL2040569 |
Oseltamivir | PA_INFA | Polymerase acidic protein | -7.14 | -6.05 | -6.21 | 31.13% | CHEMBL2040554 |
Bictegravir | PA_INFB | Polymerase acidic protein | -9.27 | N/A | N/A | N/A | N/A |
Paritaprevir | PA_INFB | Polymerase acidic protein | -10.69 | N/A | N/A | N/A | N/A |
Glimepiride | PA_INFB | Polymerase acidic protein | -7.52 | N/A | N/A | N/A | N/A |
Fedratinib | PA_INFB | Polymerase acidic protein | -7.53 | N/A | N/A | N/A | N/A |
Oseltamivir | PA_INFB | Polymerase acidic protein | -5.92 | N/A | N/A | N/A | N/A |
Bictegravir | PB2_A-H3N2 | Polymerase basic protein 2 | -9.42 | -10.01 | N/A | N/A | N/A |
Paritaprevir | PB2_A-H3N2 | Polymerase basic protein 2 | -9.63 | -8.95 | N/A | N/A | N/A |
Glimepiride | PB2_A-H3N2 | Polymerase basic protein 2 | -8.75 | -8.80 | N/A | N/A | N/A |
Fedratinib | PB2_A-H3N2 | Polymerase basic protein 2 | -8.01 | -8.73 | N/A | N/A | N/A |
Oseltamivir | PB2_A-H3N2 | Polymerase basic protein 2 | -6.23 | -6.46 | N/A | N/A | N/A |
Bictegravir | PB2_A-H5N1 | Polymerase basic protein 2 | -7.99 | -9.47 | -9.20 | N/A | N/A |
Paritaprevir | PB2_A-H5N1 | Polymerase basic protein 2 | -8.57 | -9.30 | -10.03 | N/A | N/A |
Glimepiride | PB2_A-H5N1 | Polymerase basic protein 2 | -8.41 | -8.03 | -8.56 | N/A | N/A |
Fedratinib | PB2_A-H5N1 | Polymerase basic protein 2 | -8.05 | -7.97 | -8.36 | N/A | N/A |
Oseltamivir | PB2_A-H5N1 | Polymerase basic protein 2 | -6.50 | -5.56 | -6.49 | N/A | N/A |
Bictegravir | PB2_INFB | Polymerase basic protein 2 | -9.64 | N/A | N/A | N/A | N/A |
Paritaprevir | PB2_INFB | Polymerase basic protein 2 | -10.12 | N/A | N/A | N/A | N/A |
Glimepiride | PB2_INFB | Polymerase basic protein 2 | -9.00 | N/A | N/A | N/A | N/A |
Fedratinib | PB2_INFB | Polymerase basic protein 2 | -7.83 | N/A | N/A | N/A | N/A |
Oseltamivir | PB2_INFB | Polymerase basic protein 2 | -6.25 | N/A | N/A | N/A | N/A |
Bictegravir | PB3_A-H3N2 | Polymerase basic protein 2 | -8.72 | N/A | N/A | N/A | N/A |
Paritaprevir | PB3_A-H3N2 | Polymerase basic protein 2 | -9.39 | N/A | N/A | N/A | N/A |
Glimepiride | PB3_A-H3N2 | Polymerase basic protein 2 | -7.92 | N/A | N/A | N/A | N/A |
Fedratinib | PB3_A-H3N2 | Polymerase basic protein 2 | -7.98 | N/A | N/A | N/A | N/A |
Oseltamivir | PB3_A-H3N2 | Polymerase basic protein 2 | -6.66 | N/A | N/A | N/A | N/A |
Bictegravir | PB4_A-H3N2 | Polymerase basic protein 2 | -9.98 | N/A | N/A | N/A | N/A |
Paritaprevir | PB4_A-H3N2 | Polymerase basic protein 2 | -9.38 | N/A | N/A | N/A | N/A |
Glimepiride | PB4_A-H3N2 | Polymerase basic protein 2 | -9.12 | N/A | N/A | N/A | N/A |
Fedratinib | PB4_A-H3N2 | Polymerase basic protein 2 | -8.56 | N/A | N/A | N/A | N/A |
Oseltamivir | PB4_A-H3N2 | Polymerase basic protein 2 | -6.11 | N/A | N/A | N/A | N/A |
Bictegravir | PLP_SARS | Replicase polyprotein 1a | -10.77 | -10.34 | -10.68 | 29.32% | CHEMBL213054 |
Paritaprevir | PLP_SARS | Replicase polyprotein 1a | -10.91 | -8.75 | -8.89 | 31.83% | CHEMBL212080 |
Glimepiride | PLP_SARS | Replicase polyprotein 1a | -10.56 | -11.06 | -10.34 | 32.09% | CHEMBL213543 |
Fedratinib | PLP_SARS | Replicase polyprotein 1a | -10.61 | -10.33 | -10.06 | 21.55% | CHEMBL212454 |
Oseltamivir | PLP_SARS | Replicase polyprotein 1a | -6.18 | -6.69 | -6.44 | 42.31% | CHEMBL212080 |
Bictegravir | PR_FCoV | Replicase polyprotein 1ab | -9.64 | N/A | N/A | N/A | N/A |
Paritaprevir | PR_FCoV | Replicase polyprotein 1ab | -8.67 | N/A | N/A | N/A | N/A |
Glimepiride | PR_FCoV | Replicase polyprotein 1ab | -8.17 | N/A | N/A | N/A | N/A |
Fedratinib | PR_FCoV | Replicase polyprotein 1ab | -7.52 | N/A | N/A | N/A | N/A |
Oseltamivir | PR_FCoV | Replicase polyprotein 1ab | -5.52 | N/A | N/A | N/A | N/A |
Bictegravir | PR_HCoV-229E | Replicase polyprotein 1a | -9.47 | -8.63 | N/A | N/A | N/A |
Paritaprevir | PR_HCoV-229E | Replicase polyprotein 1a | -8.69 | -8.86 | N/A | N/A | N/A |
Glimepiride | PR_HCoV-229E | Replicase polyprotein 1a | -8.15 | -7.23 | N/A | N/A | N/A |
Fedratinib | PR_HCoV-229E | Replicase polyprotein 1a | -7.41 | -7.47 | N/A | N/A | N/A |
Oseltamivir | PR_HCoV-229E | Replicase polyprotein 1a | -5.54 | -5.12 | N/A | N/A | N/A |
Bictegravir | PR_HCoV-NL63 | Replicase polyprotein 1a | -5.32 | -9.41 | N/A | N/A | N/A |
Paritaprevir | PR_HCoV-NL63 | Replicase polyprotein 1a | -6.04 | -10.07 | N/A | N/A | N/A |
Glimepiride | PR_HCoV-NL63 | Replicase polyprotein 1a | -6.29 | -8.28 | N/A | N/A | N/A |
Fedratinib | PR_HCoV-NL63 | Replicase polyprotein 1a | -5.47 | -7.76 | N/A | N/A | N/A |
Oseltamivir | PR_HCoV-NL63 | Replicase polyprotein 1a | -4.45 | -5.90 | N/A | N/A | N/A |
Bictegravir | PR_HIV1 | Gag-Pol polyprotein | -8.44 | -8.43 | -7.97 | 25.83% | CHEMBL3645128 |
Paritaprevir | PR_HIV1 | Gag-Pol polyprotein | -8.27 | -8.42 | -8.13 | 28.62% | CHEMBL492666 |
Glimepiride | PR_HIV1 | Gag-Pol polyprotein | -6.68 | -7.33 | -6.71 | 37.57% | CHEMBL492666 |
Fedratinib | PR_HIV1 | Gag-Pol polyprotein | -6.44 | -7.29 | -7.07 | 34.55% | CHEMBL450294 |
Oseltamivir | PR_HIV1 | Gag-Pol polyprotein | -5.22 | -5.46 | -5.57 | 24.40% | CHEMBL494500 |
Bictegravir | PR_HIV2 | Gag-Pol polyprotein | -8.90 | -8.45 | N/A | N/A | N/A |
Paritaprevir | PR_HIV2 | Gag-Pol polyprotein | -8.94 | -8.72 | N/A | N/A | N/A |
Glimepiride | PR_HIV2 | Gag-Pol polyprotein | -8.62 | -7.47 | N/A | N/A | N/A |
Fedratinib | PR_HIV2 | Gag-Pol polyprotein | -7.45 | -7.52 | N/A | N/A | N/A |
Oseltamivir | PR_HIV2 | Gag-Pol polyprotein | -5.92 | -5.37 | N/A | N/A | N/A |
Bictegravir | PR_HKU1 | Replicase polyprotein 1a | -8.52 | N/A | N/A | N/A | N/A |
Paritaprevir | PR_HKU1 | Replicase polyprotein 1a | -8.17 | N/A | N/A | N/A | N/A |
Glimepiride | PR_HKU1 | Replicase polyprotein 1a | -7.20 | N/A | N/A | N/A | N/A |
Fedratinib | PR_HKU1 | Replicase polyprotein 1a | -7.46 | N/A | N/A | N/A | N/A |
Oseltamivir | PR_HKU1 | Replicase polyprotein 1a | -5.58 | N/A | N/A | N/A | N/A |
Bictegravir | PR_HKU4 | Replicase polyprotein 1ab | -8.88 | -8.73 | -8.59 | N/A | N/A |
Paritaprevir | PR_HKU4 | Replicase polyprotein 1ab | -8.03 | -8.63 | -8.57 | N/A | N/A |
Glimepiride | PR_HKU4 | Replicase polyprotein 1ab | -7.53 | -7.09 | -7.89 | N/A | N/A |
Fedratinib | PR_HKU4 | Replicase polyprotein 1ab | -7.25 | -7.86 | -7.87 | N/A | N/A |
Oseltamivir | PR_HKU4 | Replicase polyprotein 1ab | -5.63 | -5.64 | -5.76 | N/A | N/A |
Bictegravir | PR_IBV | Replicase polyprotein 1a | -9.50 | N/A | N/A | N/A | N/A |
Paritaprevir | PR_IBV | Replicase polyprotein 1a | -8.97 | N/A | N/A | N/A | N/A |
Glimepiride | PR_IBV | Replicase polyprotein 1a | -8.11 | N/A | N/A | N/A | N/A |
Fedratinib | PR_IBV | Replicase polyprotein 1a | -8.13 | N/A | N/A | N/A | N/A |
Oseltamivir | PR_IBV | Replicase polyprotein 1a | -5.94 | N/A | N/A | N/A | N/A |
Bictegravir | PR_MERs | 3C-like proteinase | -8.92 | -9.59 | N/A | N/A | N/A |
Paritaprevir | PR_MERs | 3C-like proteinase | -7.94 | -8.07 | N/A | N/A | N/A |
Glimepiride | PR_MERs | 3C-like proteinase | -8.52 | -9.25 | N/A | N/A | N/A |
Fedratinib | PR_MERs | 3C-like proteinase | -7.84 | -7.81 | N/A | N/A | N/A |
Oseltamivir | PR_MERs | 3C-like proteinase | -6.04 | -6.05 | N/A | N/A | N/A |
Bictegravir | PR_PEDV | 3C-like proteinase | -9.08 | N/A | N/A | N/A | N/A |
Paritaprevir | PR_PEDV | 3C-like proteinase | -9.32 | N/A | N/A | N/A | N/A |
Glimepiride | PR_PEDV | 3C-like proteinase | -8.54 | N/A | N/A | N/A | N/A |
Fedratinib | PR_PEDV | 3C-like proteinase | -8.06 | N/A | N/A | N/A | N/A |
Oseltamivir | PR_PEDV | 3C-like proteinase | -5.91 | N/A | N/A | N/A | N/A |
Bictegravir | PR_SARS | Replicase polyprotein 1ab | -9.79 | -8.65 | -8.88 | 24.29% | CHEMBL2441745 |
Paritaprevir | PR_SARS | Replicase polyprotein 1ab | -8.33 | -8.44 | -8.60 | 26.37% | CHEMBL2441741 |
Glimepiride | PR_SARS | Replicase polyprotein 1ab | -8.33 | -8.51 | -7.97 | 31.07% | CHEMBL2441741 |
Fedratinib | PR_SARS | Replicase polyprotein 1ab | -7.71 | -8.09 | -7.88 | 17.89% | CHEMBL2441741 |
Oseltamivir | PR_SARS | Replicase polyprotein 1ab | -5.90 | -5.83 | -5.42 | 25.41% | CHEMBL2441745 |
Bictegravir | PR_SARS2 | 3C-like protease | -9.47 | N/A | N/A | N/A | N/A |
Paritaprevir | PR_SARS2 | 3C-like protease | -9.16 | N/A | N/A | N/A | N/A |
Glimepiride | PR_SARS2 | 3C-like protease | -7.83 | N/A | N/A | N/A | N/A |
Fedratinib | PR_SARS2 | 3C-like protease | -8.01 | N/A | N/A | N/A | N/A |
Oseltamivir | PR_SARS2 | 3C-like protease | -5.94 | N/A | N/A | N/A | N/A |
Bictegravir | PR_TGEV | Replicase polyprotein 1a | -8.53 | N/A | N/A | N/A | N/A |
Paritaprevir | PR_TGEV | Replicase polyprotein 1a | -8.36 | N/A | N/A | N/A | N/A |
Glimepiride | PR_TGEV | Replicase polyprotein 1a | -8.88 | N/A | N/A | N/A | N/A |
Fedratinib | PR_TGEV | Replicase polyprotein 1a | -7.64 | N/A | N/A | N/A | N/A |
Oseltamivir | PR_TGEV | Replicase polyprotein 1a | -5.78 | N/A | N/A | N/A | N/A |
Bictegravir | RT_HIV1 | Gag-Pol polyprotein | -10.97 | -11.90 | -10.84 | 30.95% | CHEMBL4109767 |
Paritaprevir | RT_HIV1 | Gag-Pol polyprotein | -10.74 | -9.25 | -10.59 | 37.04% | CHEMBL3977507 |
Glimepiride | RT_HIV1 | Gag-Pol polyprotein | -10.47 | -10.98 | -10.85 | 45.91% | CHEMBL4225004 |
Fedratinib | RT_HIV1 | Gag-Pol polyprotein | -8.09 | -8.38 | -8.33 | 32.14% | CHEMBL3683702 |
Oseltamivir | RT_HIV1 | Gag-Pol polyprotein | -8.49 | -8.19 | -8.39 | 34.78% | CHEMBL4225865 |
Bictegravir | SPIKE_HCoV-229E | Spike glycoprotein | -6.23 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_HCoV-229E | Spike glycoprotein | -7.30 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_HCoV-229E | Spike glycoprotein | -5.89 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_HCoV-229E | Spike glycoprotein | -5.84 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_HCoV-229E | Spike glycoprotein | -4.34 | N/A | N/A | N/A | N/A |
Bictegravir | SPIKE_HCoV-NL63 | Spike glycoprotein | -7.50 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_HCoV-NL63 | Spike glycoprotein | -7.52 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_HCoV-NL63 | Spike glycoprotein | -6.87 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_HCoV-NL63 | Spike glycoprotein | -6.07 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_HCoV-NL63 | Spike glycoprotein | -4.56 | N/A | N/A | N/A | N/A |
Bictegravir | SPIKE_HCoV-OC43 | Spike glycoprotein | -7.77 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_HCoV-OC43 | Spike glycoprotein | -8.57 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_HCoV-OC43 | Spike glycoprotein | -7.23 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_HCoV-OC43 | Spike glycoprotein | -7.19 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_HCoV-OC43 | Spike glycoprotein | -5.50 | N/A | N/A | N/A | N/A |
Bictegravir | SPIKE_HKU4 | Spike glycoprotein | -8.33 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_HKU4 | Spike glycoprotein | -8.17 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_HKU4 | Spike glycoprotein | -8.03 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_HKU4 | Spike glycoprotein | -6.51 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_HKU4 | Spike glycoprotein | -5.47 | N/A | N/A | N/A | N/A |
Bictegravir | SPIKE_IBV | Spike glycoprotein | -7.76 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_IBV | Spike glycoprotein | -7.91 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_IBV | Spike glycoprotein | -7.33 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_IBV | Spike glycoprotein | -7.26 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_IBV | Spike glycoprotein | -4.67 | N/A | N/A | N/A | N/A |
Bictegravir | SPIKE_MERs | Spike glycoprotein | -8.52 | -7.63 | -7.41 | N/A | N/A |
Paritaprevir | SPIKE_MERs | Spike glycoprotein | -8.59 | -9.09 | -7.49 | N/A | N/A |
Glimepiride | SPIKE_MERs | Spike glycoprotein | -8.30 | -7.40 | -6.68 | N/A | N/A |
Fedratinib | SPIKE_MERs | Spike glycoprotein | -7.03 | -6.28 | -6.38 | N/A | N/A |
Oseltamivir | SPIKE_MERs | Spike glycoprotein | -5.30 | -4.99 | -4.61 | N/A | N/A |
Bictegravir | SPIKE_MHV | Spike glycoprotein | -8.99 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_MHV | Spike glycoprotein | -9.07 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_MHV | Spike glycoprotein | -7.65 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_MHV | Spike glycoprotein | -7.74 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_MHV | Spike glycoprotein | -5.78 | N/A | N/A | N/A | N/A |
Bictegravir | SPIKE_PDCoV | Spike protein | -8.13 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_PDCoV | Spike protein | -8.50 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_PDCoV | Spike protein | -6.69 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_PDCoV | Spike protein | -6.42 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_PDCoV | Spike protein | -5.25 | N/A | N/A | N/A | N/A |
Bictegravir | SPIKE_SARS | Spike glycoprotein | -7.85 | -7.69 | N/A | N/A | N/A |
Paritaprevir | SPIKE_SARS | Spike glycoprotein | -8.27 | -8.35 | N/A | N/A | N/A |
Glimepiride | SPIKE_SARS | Spike glycoprotein | -7.76 | -7.31 | N/A | N/A | N/A |
Fedratinib | SPIKE_SARS | Spike glycoprotein | -6.78 | -6.52 | N/A | N/A | N/A |
Oseltamivir | SPIKE_SARS | Spike glycoprotein | -5.86 | -5.42 | N/A | N/A | N/A |
Bictegravir | SPIKE_SARS2 | Spike glycoprotein | -7.23 | N/A | N/A | N/A | N/A |
Paritaprevir | SPIKE_SARS2 | Spike glycoprotein | -7.28 | N/A | N/A | N/A | N/A |
Glimepiride | SPIKE_SARS2 | Spike glycoprotein | -6.94 | N/A | N/A | N/A | N/A |
Fedratinib | SPIKE_SARS2 | Spike glycoprotein | -6.62 | N/A | N/A | N/A | N/A |
Oseltamivir | SPIKE_SARS2 | Spike glycoprotein | -4.57 | N/A | N/A | N/A | N/A |